PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Not so fast: Differences in the first embryonic cell lineage decision of mammals

New research shows that all not mammals are created equal

2011-02-15
(Press-News.org) New research shows that all not mammals are created equal. In fact, this work shows that the animals most commonly used by scientists to study mammalian genetics -- mice -- develop unusually quickly and may not always be representative of embryonic development in other mammals. The study, published by Cell Press in the February 14 issue of the journal Developmental Cell, identifies significant differences in the timing of cell fate commitment during mouse and cattle embryonic development and raises important strategic implications for the generation of embryonic stem cells.

The placenta in mammals is formed from cells called trophectoderm that arise from the very first lineage decision made by the early embryo. Most trophectoderm research is performed on mice, as other mammals tend to be much harder to work with in a lab. In the mouse, the fate of trophoectoderm cells is sealed (committed) by the mid-blastocyst stage. This fate commitment is driven in part by repression of the stem cell factor Oct4.

"We were intrigued by previous observations that in mammals such as humans, cattle, pigs and rabbits Oct4 protein was not shut down in the trophoectoderm of late blastocyst embryos," explains senior author Dr. Peter L. Pfeffer from AgResearch Crown Research Institute in Hamilton, New Zealand. Using cattle as a non-rodent model system, Dr. Pfeffer and colleagues discovered that cattle trophoectoderm cells were committed to their fate much later than mouse cells, with Oct4 expression levels remaining strong for longer than in mice. In fact the authors identified the specific evolutionary changes in mouse DNA that make Oct4 behave differently in mice than in other mammals.

"Somewhat ironically, our studies in cattle led to new insight into Oct4 regulation in the mouse," explains Dr Pfeffer. "Such evolutionary differences in the regulation of the key stem cell gene Oct4 may explain the difficulty in embryonic stem cell derivation in mammals other than the mouse." Based on the fact that mouse embryos implant in the uterus at an earlier developmental stage than other mammals do, and therefore require earlier trophectoderm formation, the authors also speculate that the unusually rapid repression of Oct4 in mouse trophectoderm represented a key evolutionary step enabling early implantation.

"Establishing cattle as a second functional mammalian embryological model system challenges notions that mice are representative of either the earliest stages of mammalian development or of embryonic stem cell biology," concludes Dr. Pfeffer.

### END


ELSE PRESS RELEASES FROM THIS DATE:

Military/civilian medical experts turning attention to 'army' of injured civilians supporting wars

2011-02-15
After analyzing data on 2,155 private contractors, diplomats and other civilians supporting war efforts in Iraq and Afghanistan who were medically evacuated out of combat zones, researchers have found they are more likely to be evacuated for noncombat-related injuries, but more likely to return to work in-country after treatment for these conditions. Still, the findings of the Johns Hopkins-led research team, published online in CMAJ, the journal of the Canadian Medical Association, note that 75 percent of the nonmilitary group medically evacuated from the war zones to ...

People at risk of diabetes offer clues toward novel drugs

2011-02-15
BOSTON – February 14, 2011 – Once people develop type 2 diabetes, high blood glucose levels alter their metabolism so much that it becomes difficult to sift through all the clues to find what might enable the disease. "To identify factors that play a primary role in disease susceptibility, we want to investigate people before they get to that point," says Mary-Elizabeth Patti, M.D. of Joslin Diabetes Center. By examining people across the spectrum of diabetes—from healthy to the full-blown disease—scientists in her lab have found a molecular pathway that offers novel targets ...

New anti-clotting drug added to recommendations for treating irregular heartbeat

2011-02-15
The newly approved drug dabigatran is an alternative to warfarin to help prevent dangerous blood clots in patients with atrial fibrillation, according to updated guidelines from the American College of Cardiology, American Heart Association and the Heart Rhythm Society. The "Focused Update" — published in Circulation: Journal of the American Heart Association, Journal of the American College of Cardiology and HeartRhythm Journal — specifically updates the section on emerging antithrombotic agents in atrial fibrillation treatment guidelines released by the three organizations ...

A hunk of a target for treating breast cancer

2011-02-15
Among women with breast cancer, approximately 25% have a subtype that is characterized by high levels of expression of the protein HER2. HER2-positive breast cancer tends to be more aggressive than other breast cancer subtypes. Increased molecular understanding of why HER2-positive breast cancer is so aggressive could aid in the development of new therapeutics. By studying mouse models, a team of researchers, led by Lewis Chodosh, at the University of Pennsylvania School of Medicine, Philadelphia, has now identified a key role for the protein Hunk in the formation of tumors ...

New combination therapy for solid tumors?

2011-02-15
Most, if not all, solid tumors contain regions that are not well oxygenated. Tumor cells in these regions, which are known as hypoxic regions, are usually resistant to the death-inducing effects of chemotherapeutics. But now, Caroline Dive and colleagues, at Manchester University, United Kingdom, have identified a compound (ABT-737) that induces human cancer cells exposed to hypoxic conditions in vitro to undergo a form of cell death known as apoptosis. In addition, cells in hypoxic regions of human tumors xenografted in mice were susceptible to ABT-737–induced apoptotic ...

JCI online early table of contents: Feb. 14, 2011

2011-02-15
EDITOR'S PICK: A hunk of a target for treating breast cancer Among women with breast cancer, approximately 25% have a subtype that is characterized by high levels of expression of the protein HER2. HER2-positive breast cancer tends to be more aggressive than other breast cancer subtypes. Increased molecular understanding of why HER2-positive breast cancer is so aggressive could aid in the development of new therapeutics. By studying mouse models, a team of researchers, led by Lewis Chodosh, at the University of Pennsylvania School of Medicine, Philadelphia, has now identified ...

X-rays show why van Gogh paintings lose their shine

X-rays show why van Gogh paintings lose their shine
2011-02-15
This release is available in French. VIDEO: A microsample is taken from the van Gogh painting "Bank of river Seine " on display at the van Gogh Museum in Amsterdam (Netherlands), and then analyzed at the X-rays microscope... Click here for more information. Scientists have identified a complex chemical reaction responsible for the degradation of two paintings by Vincent ...

Medicare costs in last 6 months of life driven by patient variables twice as much as geography

2011-02-15
A study by Mount Sinai School of Medicine finds that Medicare costs at the end of life are influenced more by patient characteristics, such as ability to function, the severity of the illness, and family support than by regional factors, such as the number of hospital beds available. The study will be published February 15 in The Annals of Internal Medicine. "These new findings show that the reasons for wide variation in Medicare costs across the United States are much more complicated than previously thought," said lead author Amy Kelley, MD, Assistant Professor in ...

UC San Diego biologists gain new insights into brain circuit wiring

2011-02-15
Neurobiologists at UC San Diego have discovered new ways by which nerves are guided to grow in highly directed ways to wire the brain during embryonic development. Their finding, detailed in a paper in the February 15 issue of the journal Developmental Cell, provides a critical piece of understanding to the longstanding puzzle of how the human brain wires itself into the complex networks that underlie our behavior. The discovery concerns the movements of a highly sensitive and motile structure at the tips of growing nerves called a growth cone. For more than a century, ...

Less is more when prescribing acid suppressive drugs for non-ICU patients

2011-02-15
BOSTON – Over the last several decades, the prophylactic use of acid-suppressive medications to help prevent gastrointestinal bleeding (GI) in hospitalized patients has increased significantly, with some studies estimating that as many as 40 to 70 percent of all medical inpatients are given these drugs at some point during their hospitalization. But, for patients who are not critically ill, the actual incidence of GI bleeding has not been well investigated. Now, a study led by researchers at Beth Israel Deaconess Medical Center (BIDMC) and reported in today's on-line ...

LAST 30 PRESS RELEASES:

Study finds moral costs in over-pricing for essentials

Australian scientists uncover secrets of yellow fever

Researchers develop high-performance biochar for efficient carbon dioxide capture

Biodegradable cesium nanosalts activate anti-tumor immunity via inducing pyroptosis and intervening in metabolism

Can bamboo help solve the plastic pollution crisis?

Voting behaviour in elections strongly linked to future risk of death

Significant variations in survival times of early onset dementia by clinical subtype

Research finds higher rare risk of heart complications in children after COVID-19 infection than after vaccination

Oxford researchers develop ‘brain-free’ robots that move in sync, powered entirely by air

The science behind people who never forget a face

Study paints detailed picture of forest canopy damage caused by ‘heat dome’

New effort launched to support earlier diagnosis, treatment of aortic stenosis

Registration and Abstract Submission Open for “20 Years of iPSC Discovery: A Celebration and Vision for the Future,” 20-22 October 2026, Kyoto, Japan

Half-billion-year-old parasite still threatens shellfish

Engineering a clearer view of bone healing

Detecting heart issues in breast cancer survivors

Moffitt study finds promising first evidence of targeted therapy for NRAS-mutant melanoma

Lay intuition as effective at jailbreaking AI chatbots as technical methods

USC researchers use AI to uncover genetic blueprint of the brain’s largest communication bridge

Tiny swarms, big impact: Researchers engineering adaptive magnetic systems for medicine, energy and environment

MSU study: How can AI personas be used to detect human deception?

Slowed by sound: A mouse model of Parkinson’s Disease shows noise affects movement

Demographic shifts could boost drug-resistant infections across Europe

Insight into how sugars regulate the inflammatory disease process

PKU scientists uncover climate impacts and future trends of hailstorms in China

Computer model mimics human audiovisual perception

AC instead of DC: A game-changer for VR headsets and near-eye displays

Prevention of cardiovascular disease events and deaths among black adults via systolic blood pressure equity

Facility-based uptake of colorectal cancer screening in 45- to 49-year-olds after US guideline changes

Scientists uncover hidden nuclear droplets that link multiple leukemias and reveal a new therapeutic target

[Press-News.org] Not so fast: Differences in the first embryonic cell lineage decision of mammals
New research shows that all not mammals are created equal